GC0000150A - Pharmaceutical solutions of levosimendan. - Google Patents

Pharmaceutical solutions of levosimendan.

Info

Publication number
GC0000150A
GC0000150A GCP20001050A GC0000150A GC 0000150 A GC0000150 A GC 0000150A GC P20001050 A GCP20001050 A GC P20001050A GC 0000150 A GC0000150 A GC 0000150A
Authority
GC
Cooperation Council for the Arab states of the Gulf
Prior art keywords
levosimendan
pharmaceutical solutions
pharmaceutical
solutions
Prior art date
Application number
Inventor
Reijo Backstrom
Paivi Granvik
Ritva Haikala
Sirpa Pelttari
Eva Saukko
Reija Yrjola
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Priority to GCP20001050 priority Critical patent/GC0000150A/en
Application granted granted Critical
Publication of GC0000150A publication Critical patent/GC0000150A/en

Links

GCP20001050 2000-11-26 2000-11-26 Pharmaceutical solutions of levosimendan. GC0000150A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GCP20001050 GC0000150A (en) 2000-11-26 2000-11-26 Pharmaceutical solutions of levosimendan.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GCP20001050 GC0000150A (en) 2000-11-26 2000-11-26 Pharmaceutical solutions of levosimendan.

Publications (1)

Publication Number Publication Date
GC0000150A true GC0000150A (en) 2005-06-29

Family

ID=34856819

Family Applications (1)

Application Number Title Priority Date Filing Date
GCP20001050 GC0000150A (en) 2000-11-26 2000-11-26 Pharmaceutical solutions of levosimendan.

Country Status (1)

Country Link
GC (1) GC0000150A (en)

Similar Documents

Publication Publication Date Title
MXPA03004504A (en) Oral treatment systems.
MXPA03000771A (en) New pharmaceutical composition.
MXPA03002410A (en) 4-amino-quinazolines.
ZA200206198B (en) New aza-indolyl derivatives.
MXPA03001419A (en) Therapeutic combination.
MXPA03005445A (en) I2.
ZA200201828B (en) Pharmaceutical solutions of levosimendan.
ZA200101012B (en) Pharmaceutical combinations.
ZA200210206B (en) Expression system.
MXPA02008907A (en) Capsules.
EG23262A (en) Delta -pyrrolines.
MXPA01007826A (en) Fully-locking torque-proportioning differential.
MXPA03001591A (en) 10-aryl-11-h.
MXPA03001877A (en) 2-guanidino-4-aryl-quinazoline.
ZA200205482B (en) Aminosulfonylbiphenyl derivatives.
MXPA03002668A (en) Sulfonylguanidine.
MXPA03002411A (en) 4-amino-quinazolines.
ZA200206150B (en) Aminomethyl-phenyl-cyclohexanone derivatives.
MXPA03002521A (en) Triazolo-epothilones.
ZA200210361B (en) Method of administering bishosphonates.
ZA200107349B (en) Intimate napkin.
GC0000150A (en) Pharmaceutical solutions of levosimendan.
GB0021487D0 (en) Pharmaceutical
GB0007510D0 (en) D.o.t.t.s
ZA200302241B (en) Triazolo-epothilones.